← Evidence map

ArticleLeukemia2026

Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL.

Emigdio Álvarez-Corrales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41951939